Where it comes from
- Made in
- The same neurons as vasopressin, one copeptin for every vasopressin
- Sent out by
- Exactly with vasopressin: thirst, low volume, stress
- Acts on
- None
What it does
- Helps pro-vasopressin fold in the neuron
- Lasts in blood where vasopressin lasts minutes and sticks to platelets
- A mirror of vasopressin release
In medicine
- The modern test for diabetes insipidus: copeptin after hypertonic saline tells vasopressin deficiency from primary polydipsia better than the water deprivation test; copeptin after arginine is simpler but less accurate 1
- A low copeptin with a normal troponin at presentation lets a heart attack be ruled out early in people at low risk, which matters most for those who arrive before troponin has had time to rise 3
- A stress marker that predicts outcome in pneumonia, stroke and sepsis 4
Beyond the body’s own use
- What it settles: with a cutoff of 4.9 pmol/L after hypertonic saline, copeptin reached the right diagnosis in 96.5 per cent of 141 patients with hypotonic polyuria, against 76.6 per cent for the water deprivation test 1
- What it demands: that test works by raising plasma sodium and needs close monitoring, and the simpler arginine-stimulated version was less accurate, 93 per cent in the pooled cohorts 2
- What it cannot do alone: a single copeptin does not exclude a heart attack. Paired with a troponin in 902 patients it allowed safe early discharge of low-risk cases, with a 0.6 per cent event rate among those sent home 3
- What it will not tell you: as a stress marker it tracks how ill someone is and points to no particular cause, so a raised level in pneumonia, stroke or sepsis carries prognosis and not diagnosis 4
Sources
- Fenske et al., A copeptin-based approach in the diagnosis of diabetes insipidus, New England Journal of Medicine 2018
- Winzeler et al., Arginine-stimulated copeptin in the differential diagnosis of diabetes insipidus, Lancet 2019
- Möckel et al., Early discharge using single cardiac troponin and copeptin testing, European Heart Journal 2015
- Christ-Crain, Vasopressin and copeptin in health and disease, Reviews in Endocrine and Metabolic Disorders 2019
This card describes what a medicine is for and what the evidence says; it recommends nothing. Talk to your clinician about anything you read here.